Efficacy and Cardiovascular Adverse Effects of Erythropoiesis Stimulating Agents in the Treatment of Cancer-Related Anemia: A Systematic Review of Randomized Controlled Trials

Anemia is a common complication of cancer. Treatment of anemia in cancer is crucial as anemia adversely affects the quality of life, therapeutic outcomes, and overall survival. Erythropoiesis stimulating agents (ESAs) are valuable drugs for treating cancer-related anemia. Cardiovascular adverse effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gergal Gopalkrishna Rao, Sanjay Rao, Bugazia, Seif, Dhandapani, Tamil Poonkuil Mozhi, Tara, Anjli, Garg, Ishan, Patel, Jaimin N, Yeon, Jimin, Memon, Marrium S, Muralidharan, Abilash, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432433/
https://www.ncbi.nlm.nih.gov/pubmed/34527499
http://dx.doi.org/10.7759/cureus.17835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432433/
https://www.ncbi.nlm.nih.gov/pubmed/34527499
http://dx.doi.org/10.7759/cureus.17835

Ejemplares similares